reports
BeammWave AB: 1 director
A director at BeammWave AB bought 133,334 shares at 3.000SEK and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
DSM-Firmenich AG: 1 director
A director at DSM-Firmenich AG sold 5,035 shares at 105.950EUR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
BNP Paribas Bank Polska S.A.: 1 director
A director at BNP Paribas Bank Polska S.A. sold 5,256 shares at 94.233PLN and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Stellantis to Webcast Investor Day on June 13
Stellantis to Webcast Investor Day on June 13 Stellantis to Webcast Investor Day on June 13 AMSTERDAM, May 23, 2024 – Stellantis Chief Executive Officer Carlos Tavares, Chief Financial Officer Natalie Knight and other members of the top executive team will share Stellantis’ view on the dynamic, challenging market and how the Company is well-positioned to compete for industry leadership at the Stellantis Investor Day on Thursday, June 13, at 8:00 a.m. EDT / 2:00 p.m. CEST in Auburn Hills, Michigan, U.S. To watch the live event, visit the following webcast link: Details for watching t...
Sanergy Group Limited: 1 director
A director at Sanergy Group Limited sold 32,000,000 shares at 3.600HKD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
United Energy Group Ltd: 1 director
A director at United Energy Group Ltd sold 38,000,000 shares at 0.638HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Beijing Enterprises Water Group Ltd: 1 director
A director at Beijing Enterprises Water Group Ltd sold 586,000 shares at 2.500HKD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
Inari Amertron Bhd: 1 director
A director at Inari Amertron Bhd sold 1,400,000 shares at 0.000MYR and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Monro, Inc. Announces Fourth Quarter and Fiscal 2024 Financial Results
ROCHESTER, N.Y.--(BUSINESS WIRE)-- Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today announced financial results for its fourth quarter and fiscal year ended March 30, 2024. Fourth Quarter Results Sales for the fourth quarter of the fiscal year ended March 30, 2024 (“fiscal 2024”) decreased 0.2% to $310.1 million, as compared to $310.8 million for the fourth quarter of the fiscal year ended March 25, 2023 (“fiscal 2023”). Fiscal 2024 was a 53-week year with 368 selling days as compared to 361 selling days in fiscal 2023, and therefore inc...
Plato Gold Reports on First Quarter Results
Plato Gold Reports on First Quarter Results Toronto, ON, May 23, 2024 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) an exploration company with a portfolio of properties in Northern Ontario and Santa Cruz, Argentina is pleased to report the three months financial results for fiscal 2024 and 2023, as summarized below: Three Months Ended (Unaudited) March 31,March 31, 2024 2023 Income$513$520Net Loss and Comprehensive Loss $52,664$48,905Loss per common share - basic and diluted$0.00$0.00Weighted average numbe...
Apogee Therapeutics to Participate in Upcoming June Investor Conferenc...
Apogee Therapeutics to Participate in Upcoming June Investor Conferences SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, COPD, asthma and other inflammatory and immunology indications, today announced that members of management will participate at the following upcoming investor conferences: Jefferies Global Healthcare Conference Date: Thursday, June 6, 2024Time: 8:30 a.m. ET Goldman Sachs 45th Annual Global Healthcare ConferenceDate: Mond...
Xplus S.A.: 1 director
A director at Xplus S.A. bought 60,000 shares at 1.465PLN and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Tonking New Energy Group Holdings Limited: 1 director
A director at Tonking New Energy Group Holdings Limited bought 28,626,000 shares at 0.100HKD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ...
Prinx Chengshan (Cayman) Holding Limited: 1 director
A director at Prinx Chengshan (Cayman) Holding Limited bought 1,200,000 shares at 7.250HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
Conferize’s fortegningsemission
Conferize’s fortegningsemission Selskabsmeddelelse nr. 12/2024København, den 23. maj 2024Conferize’s fortegningsemission Conferize A/S har med succes gennemført sin fortegningsemission, hvor brutto provenuet bliver DKK 3.931.842,10 og med et forventet netto provenuet på DKK 3.200.000,00. Emissionen bliver tegnet af over 300 eksisterende og nye investorer. Samtidig er det aftalt med 2 af garanterne, som ikke deltog i fortegningsemissionen, at de tegner nye aktier for en kursværdi på DKK 2.000.000,00 inden den 1. juli 2024 i en rettet emission på kurs 0,01 DKK pr. aktie. Med de...
Kuehne + Nagel International AG: 1 director
A director at Kuehne + Nagel International AG bought 140 shares at 242.000CHF and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Metaplanet Inc: 1 director
A director at Metaplanet Inc sold 6,174,400 shares at 0.000JPY and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
- Lynn Song
- Min Joo Kang
- Rob Carnell
Tourmaline Bio to Present at the Jefferies Global Healthcare Conferenc...
Tourmaline Bio to Present at the Jefferies Global Healthcare Conference NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, today announced that Sandeep Kulkarni, CEO, is expected to participate in the following investor conference: Jefferies Global Healthcare Conference, New YorkCorporate PresentationThursday, June 6, 2024 at 2:30 pm ET A live webcast and replay will be...
Man Group PLC : Form 8.3 - Barratt Developments plc
Man Group PLC : Form 8.3 - Barratt Developments plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant secur...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.